HHV-6 and atypical lymphoproliferative disorders: are only qualitative molecular examinations sufficient to support a pathogenetic role?

References

• Fazakas A, Csire M, Berencsi G, et al Multicentric plasmocytic Castelman's disease with polyneuropathy, organomegaly, endocrinopathy, M protein, skin changes syndrome and coexistent human herpes virus-6 infection – a possible relationship. Leuk Lymphoma 2009;50:1661–1665.
   PubMed Web of Science ®Google Scholar
• Barozzi P, Luppi M, Masini L, et al Lymphotropic herpes virus (EBV, HHV-6, HHV-8) DNA sequences in HIV negative Castleman's disease. Clin Mol Pathol 1996;49:M232–M235.
   PubMedGoogle Scholar
• Di Luca D, Dolcetti R, Mirandola P, et al Human herpesvirus 6: a survey of presence and variant distribution in normal peripheral lymphocytes and lymphoproliferative disorders. J Infect Dis 1994;170:211–215.
   PubMed Web of Science ®Google Scholar
• Luppi M, Marasca R, Barozzi P, et al Frequent detection of human herpesvirus-6 sequences by polymerase chain reaction in paraffin-embedded lymph nodes from patients with angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma. Leuk Res 1993;17:1003–1011.
   PubMed Web of Science ®Google Scholar
• Maric I, Bryant R, Abu-Asab M, et al Human herpesvirus-6-associated acute lymphadenitis in immunocompetent adults. Mod Pathol 2004;17:1427–1433.
   PubMed Web of Science ®Google Scholar
• Luppi M, Barozzi P, Garber R, et al Expression of human herpesvirus-6 antigens in benign and malignant lymphoproliferative diseases. Am J Pathol 1998;153:815–823.
   PubMed Web of Science ®Google Scholar
• Gautheret-Dejean A, Manichanh C, Thien-Ah-Koon F, et al Development of a real-time polymerase chain reaction assay for the diagnosis of human herpesvirus-6 infection and application to bone marrow transplant patients. J Virol Methods 2002;100:27–35.
   PubMed Web of Science ®Google Scholar
• Boutolleau D, Duros C, Bonnafous C, et al Identification of human herpesvirus-6 variants A and B by primer-specific real-time PCR may help to revisit their specific role in pathology. J Clin Virol 2006;35:257–263.
   PubMed Web of Science ®Google Scholar
• Torelli G, Barozzi P, Marasca R, et al Targeted integration of human herpesvirus-6 in the p arm of chromosome 17 of human peripheral blood mononuclear cells in vivo. J Med Virol 1995;46:178–188.
   PubMed Web of Science ®Google Scholar
• Luppi M, Marasca R, Barozzi P, et al Three cases of human herpesvirus-6 latent infection: integration of viral genome in peripheral blood mononuclear cell DNA. J Med Virol 1993;40:44–52.
   PubMed Web of Science ®Google Scholar
• Ward KN, Leong HN, Nacheva EP, et al Human herpesvirus 6 chromosomal integration in immunocompetent patients results in high level of viral DNA in blood, sera and hair follicles. J Clin Microbiol 2006;44:1571–1574.
   PubMed Web of Science ®Google Scholar
• Potenza L, Barozzi P, Masetti M, et al Prevalence of human herpesvirus-6 chromosomal integration (CIHHV-6) in Italian solid organ and allogeneic stem cell transplant patients. Am J Transplant 2009;9:1–8.
   PubMed Web of Science ®Google Scholar
• Ward KN. The natural history and laboratory diagnosis of human herpesvirus-6 and -7 infections in the immunocompetent. J Clin Virol 2005;32:183–193.
   PubMed Web of Science ®Google Scholar
• Akashi K, Eizuru Y, Sumiyoshi Y, et al Severe infectious mononucleosis-like syndrome and primary human herpesvirus 6 infection in an adult. N Engl J Med 1993;329:168–171.
   PubMed Web of Science ®Google Scholar
• De Oliveira Vianna RA, Siqueira MM, Camacho LA, et al The accuracy of anti-human herpesvirus 6 IgM detection in children with recent primary infection. J Virol Methods 2008;153:273–275.
   PubMed Web of Science ®Google Scholar
• Suga S, Yoshikawa T, Asano Y, et al IgM neutralizing antibody responses to human herpesvirus-6 in patients with exanthem subitum or organ transplantation. Microbiol Immunol 1992;36:495–506.
   PubMed Web of Science ®Google Scholar
• Yoshida M, Torigoe S, Yamada M. Elucidation of the cross-reactive immunoglobulin M response to human herpesvirus 6 and 7 on the basis of neutralizing antibodies. Clin Diagn Lab Immunol 2002;9:394–402.
   PubMedGoogle Scholar
• Imbert-Marcille BM, Tang XW, Lepelletier D, et al Human herpesvirus 6 infection after autologous or allogeneic stem cell transplantation: a single-center prospective longitudinal study of 92 patients. Clin Infect Dis 2000;31:881–886.
   PubMed Web of Science ®Google Scholar
• Seror E, Coquerel B, Gautheret-Dejean A, et al Quantitation of human herpesvirus 6 genome in children with acute lymphoblastic leukemia. J Med Virol 2008;80:689–693.
   PubMed Web of Science ®Google Scholar
• Ljungman P. β-Herpesvirus challenges in the transplant recipient. J Infect Dis 2002;186(Suppl 1):S99–S109.
   PubMed Web of Science ®Google Scholar
• Zerr DM, Corey L, Huang ML, et al Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation. Clin Infect Dis 2005;40:932–940.
   PubMed Web of Science ®Google Scholar
• Knox KK, Carrigan DR. Chronic myelosuppression associated with persistent bone marrow infection due to human herpesvirus 6 in a bone marrow transplant recipient. Clin Infect Dis 1996;22:174–175.
   PubMed Web of Science ®Google Scholar
• Potenza L, Luppi M, Barozzi P, et al HHV-6A in syncytial giant-cell hepatitis. N Engl J Med 2008;359:593–602.
   PubMed Web of Science ®Google Scholar